0001711456-17-000005.txt : 20171027 0001711456-17-000005.hdr.sgml : 20171027 20171027202731 ACCESSION NUMBER: 0001711456-17-000005 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140123 FILED AS OF DATE: 20171027 DATE AS OF CHANGE: 20171027 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LLC Synbio CENTRAL INDEX KEY: 0001711456 STATE OF INCORPORATION: 1Z FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37937 FILM NUMBER: 171160545 BUSINESS ADDRESS: STREET 1: 25 LITER KRASNOVO KURSANTA STREET CITY: ST. PETERSBURG STATE: 1Z ZIP: 197110 BUSINESS PHONE: 79036888758 MAIL ADDRESS: STREET 1: 25 LITER KRASNOVO KURSANTA STREET CITY: ST. PETERSBURG STATE: 1Z ZIP: 197110 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Xenetic Biosciences, Inc. CENTRAL INDEX KEY: 0001534525 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 452952962 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 99 HAYDEN AVENUE, SUITE 230 CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-778-7720 MAIL ADDRESS: STREET 1: 99 HAYDEN AVENUE, SUITE 230 CITY: LEXINGTON STATE: MA ZIP: 02421 FORMER COMPANY: FORMER CONFORMED NAME: General Sales & Leasing, Inc. DATE OF NAME CHANGE: 20130227 FORMER COMPANY: FORMER CONFORMED NAME: GENERAL AIRCRAFT INC. DATE OF NAME CHANGE: 20111108 3 1 edgar.xml PRIMARY DOCUMENT X0206 3 2014-01-23 0 0001534525 Xenetic Biosciences, Inc. XBIO 0001711456 LLC Synbio 25 LITER KRASNOVO KURSANTA ST. ST. PETERSBURG 1Z 197 110 RUSSIAN FEDERATION 0 0 1 0 Common Stock 821567 D Series A Preferred Stock 970000 D Warrants 25.41 2014-12-31 2019-12-30 Common Stock 204394 D The Reporting Person owns warrants exercisable into 204,394 shares of Common Stock. Such warrants are subject to performance vesting. The vesting milestones need to be achieved by December 31, 2017 (50%) and July 31, 2018 (50%). The amount of shares of Common Stock into which such warrants are exercisable was calculated for the purposes of this report without giving effect to any performance vesting limitations. Erin J. Kirchner, Attorney-in-Fact 2017-10-27